Anti-metastasis activity of curcumin against breast cancer via the inhibition of stem cell-like properties and EMT
- PMID: 31005718
- DOI: 10.1016/j.phymed.2018.11.001
Anti-metastasis activity of curcumin against breast cancer via the inhibition of stem cell-like properties and EMT
Abstract
Background: Curcumin is a polyphenolic compound with potent chemopreventive and anti-cancer efficacy.
Purpose: To explore the potential anti-metastasis efficacy of curcumin in breast cancer stem-like cells (BCSCs), which are increasingly considered to be the origin of the recurrence and metastasis of breast cancer.
Methods: A CCK8 assay was performed to evaluate cell viability, and a colony formation assay was conducted to determine cell proliferation in MCF-7 and MDA-MB-231 adherent cells. Transwell and wound healing assays were used to detect the effect of curcumin on cell migration and invasion in MDA-MB-231 cells. Mammospheres were cultured with serum free medium (SFM) for three generations and the BCSC surface marker CD44+CD24-/low subpopulation was measured by flow cytometry. Mammosphere formation and differentiation abilities were determined after cell treatment with curcumin. Then, a reverse transcription-quantitative polymerase chain reaction assay was conducted to detect the relative mRNA level of epithelial-mesenchymal transition (EMT) marker genes and western blot analysis was performed to determine the protein expression of stem cell genes in mammospheres treated with curcumin.
Results: Curcumin exhibited anti-proliferative and colony formation inhibiting activities in both the MCF-7 and MDA-MB-231 cell lines. It also suppressed the migration and invasion of MDA-MB-231 cells. The CD44+CD24-/low subpopulation was larger in mammospheres when MCF-7 and MDA-MB-231 adherent cells were cultured with SFM. Further studies revealed that curcumin inhibited mammosphere formation and differentiation abilities. Moreover, curcumin down-regulated the mRNA expression of Vimentin, Fibronectin, and β-catenin, and up-regulated E-cadherin mRNA expression levels. Western blot analysis demonstrated that curcumin decreased the protein expression of stem cell genes including Oct4, Nanog and Sox2.
Conclusion: The results of the present study suggest that the inhibitor effects of curcumin on breast cancer cells may be related to resistance to cancer stem-like characters and the EMT process. These data indicate that curcumin could function as a type of anti-metastasis agent for breast cancer.
Keywords: Breast cancer; Breast cancer stem-like cells; Curcumin; Epithelial-mesenchymal transition; Mammospheres; Metastasis.
Copyright © 2018. Published by Elsevier GmbH.
Similar articles
-
Curcumin inhibits the invasion and metastasis of triple negative breast cancer via Hedgehog/Gli1 signaling pathway.J Ethnopharmacol. 2022 Jan 30;283:114689. doi: 10.1016/j.jep.2021.114689. Epub 2021 Sep 28. J Ethnopharmacol. 2022. PMID: 34592340
-
Effect of Melatonin in Epithelial Mesenchymal Transition Markers and Invasive Properties of Breast Cancer Stem Cells of Canine and Human Cell Lines.PLoS One. 2016 Mar 2;11(3):e0150407. doi: 10.1371/journal.pone.0150407. eCollection 2016. PLoS One. 2016. PMID: 26934679 Free PMC article.
-
Curcumin inhibits breast cancer stem cell migration by amplifying the E-cadherin/β-catenin negative feedback loop.Stem Cell Res Ther. 2014 Oct 14;5(5):116. doi: 10.1186/scrt506. Stem Cell Res Ther. 2014. PMID: 25315241 Free PMC article.
-
Curcumin: a potent agent to reverse epithelial-to-mesenchymal transition.Cell Oncol (Dordr). 2019 Aug;42(4):405-421. doi: 10.1007/s13402-019-00442-2. Epub 2019 Apr 13. Cell Oncol (Dordr). 2019. PMID: 30980365 Review.
-
Epithelial mesenchymal transition traits in human breast cancer cell lines parallel the CD44(hi/)CD24 (lo/-) stem cell phenotype in human breast cancer.J Mammary Gland Biol Neoplasia. 2010 Jun;15(2):235-52. doi: 10.1007/s10911-010-9175-z. Epub 2010 Jun 4. J Mammary Gland Biol Neoplasia. 2010. PMID: 20521089 Review.
Cited by
-
Curcumin suppresses metastasis of triple-negative breast cancer cells by modulating EMT signaling pathways: An integrated study of bioinformatics analysis.Medicine (Baltimore). 2024 Feb 23;103(8):e37264. doi: 10.1097/MD.0000000000037264. Medicine (Baltimore). 2024. PMID: 38394486 Free PMC article.
-
The function of natural compounds in important anticancer mechanisms.Front Oncol. 2023 Jan 4;12:1049888. doi: 10.3389/fonc.2022.1049888. eCollection 2022. Front Oncol. 2023. PMID: 36686745 Free PMC article. Review.
-
Active Components of Traditional Chinese Medicinal Material for Multiple Myeloma: Current Evidence and Future Directions.Front Pharmacol. 2022 Jan 27;13:818179. doi: 10.3389/fphar.2022.818179. eCollection 2022. Front Pharmacol. 2022. PMID: 35153791 Free PMC article. Review.
-
TRG16, targeted by miR-765, inhibits breast cancer stem cell-like properties via regulating the NF-κB pathway.Mol Cell Biochem. 2022 Dec;477(12):2801-2816. doi: 10.1007/s11010-022-04480-7. Epub 2022 Jun 1. Mol Cell Biochem. 2022. PMID: 35648115
-
Immune Effect of Active Components of Traditional Chinese Medicine on Triple-Negative Breast Cancer.Front Pharmacol. 2021 Dec 3;12:731741. doi: 10.3389/fphar.2021.731741. eCollection 2021. Front Pharmacol. 2021. PMID: 34925002 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous